Holger Weis - Net Worth and Insider Trading
Holger Weis Net Worth
The estimated net worth of Holger Weis is at least $10,778 dollars as of 2024-05-21. Holger Weis is the Director of Alaunos Therapeutics Inc and owns about 9,291 shares of Alaunos Therapeutics Inc (TCRT) stock worth over $10,778. Details can be seen in Holger Weis's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the assumption that Holger Weis has not made any transactions after 2021-09-01 and currently still holds the listed stock(s).
Transaction Summary of Holger Weis
Holger Weis Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, Holger Weis owns 1 companies in total, including Alaunos Therapeutics Inc (TCRT) .
Click here to see the complete history of Holger Weis’s form 4 insider trades.
Insider Ownership Summary of Holger Weis
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| TCRT | Alaunos Therapeutics Inc | 2022-06-22 | director |
Holger Weis Latest Holdings Summary
Holger Weis currently owns a total of 1 stock. Holger Weis owns 9,291 shares of Alaunos Therapeutics Inc (TCRT) as of September 1, 2021, with a value of $10,778.
Latest Holdings of Holger Weis
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| TCRT | Alaunos Therapeutics Inc | 2021-09-01 | 9,291 | 1.16 | 10,778 |
Holding Weightings of Holger Weis
Holger Weis Form 4 Trading Tracker
According to the SEC Form 4 filings, Holger Weis has made a total of 1 transactions in Alaunos Therapeutics Inc (TCRT) over the past 5 years, including 1 buys and 0 sells. The most-recent trade in Alaunos Therapeutics Inc is the acquisition of 3,333 shares on September 1, 2021, which cost Holger Weis around $91,500.
Insider Trading History of Holger Weis
- 1
Holger Weis Trading Performance
GuruFocus tracks the stock performance after each of Holger Weis's buying transactions within different timeframes. To be detailed, the average return of stocks after 3 months bought by Holger Weis is -29.05%. GuruFocus also compares Holger Weis's trading performance to market benchmark return within the same time period. The performance of stocks bought by Holger Weis within 3 months outperforms 0 times out of 1 transactions in total compared to the return of S&P 500 within the same period.
You can select different timeframes to see how Holger Weis's insider trading performs compared to the benchmark.
Performance of Holger Weis
Average Return
Outperforming Transactions
| 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | 3 Years | |
|---|---|---|---|---|---|---|
| Return(%) | 2.79 | | | | | |
| Relative Return to S&P 500(%) | 6.48 | | | | | |
Holger Weis Ownership Network
Holger Weis Owned Company Details
What does Alaunos Therapeutics Inc do?
Who are the key executives at Alaunos Therapeutics Inc?
Holger Weis is the director of Alaunos Therapeutics Inc. Other key executives at Alaunos Therapeutics Inc include director & Chief Executive Officer Boyle Kevin S. Sr. , VP & Finance Michael Wong , and See Remarks Abhishek K Srivastava .
Alaunos Therapeutics Inc (TCRT) Insider Trades Summary
Over the past 18 months, Holger Weis made no insider transaction in Alaunos Therapeutics Inc (TCRT). Other recent insider transactions involving Alaunos Therapeutics Inc (TCRT) include a net purchase of 1,250,000 shares made by Jaime Vieser , a net purchase of 750,000 shares made by Robert W Postma , and a net sale of 68,014 shares made by Boyle Kevin S. Sr. .
In summary, during the past 3 months, insiders sold 0 shares of Alaunos Therapeutics Inc (TCRT) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 4,534 shares of Alaunos Therapeutics Inc (TCRT) were sold and 133,333 shares were bought by its insiders, resulting in a net purchase of 128,799 shares.
Alaunos Therapeutics Inc (TCRT)'s detailed insider trading history can be found in Insider Trading Tracker table.
Alaunos Therapeutics Inc Insider Transactions
Holger Weis Mailing Address
Above is the net worth, insider trading, and ownership report for Holger Weis. You might contact Holger Weis via mailing address: C/o Ziopharm Oncology, Inc., One First Avenue, Parris Bldg 34, Boston Ma 02129.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
